{"id":1842,"date":"2023-04-06T16:10:11","date_gmt":"2023-04-06T16:10:11","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1842"},"modified":"2026-02-23T00:16:10","modified_gmt":"2026-02-23T00:16:10","slug":"germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/","title":{"rendered":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze)"},"content":{"rendered":"

Wilms tumors, a rare form of kidney cancer that typically affects children, can be caused by high-penetrance genetic or epigenetic factors. However, studies systematically examining both these aspects of the disease are scarce. In a new study, researchers offered germline whole-genome sequencing to all participants diagnosed with Wilms tumors from 2016 to 2021 in Denmark. Across 24 patients, they found that a third had either genetic predisposition or an indicator of susceptibility to Wilms tumors. This third of patients was exclusively female, suggesting that the majority of Wilms tumors in females may have underlying (epi)genetic origins. With this, the study sheds light on the long-observed, yet unexplained, overrepresentation of females among patients with Wilms tumor and underscores the importance of carefully evaluating patients genetically to facilitate early detection of underlying predisposition, which could impact treatment, follow-up, and genetic counseling. (https:\/\/jmg.bmj.com\/content\/early\/2023\/04\/04\/jmg-2022-108982<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Wilms tumors, a rare form of kidney cancer that typically affects children, can be caused by high-penetrance genetic or epigenetic factors. However, studies systematically examining both these aspects of the disease are scarce. In a new study, researchers offered germline whole-genome sequencing to all participants diagnosed with Wilms tumors from 2016 to 2021 in Denmark. […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1842","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nGermline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Wilms tumors, a rare form of kidney cancer that typically affects children, can be caused by high-penetrance genetic or epigenetic factors. However, studies systematically examining both these aspects of the disease are scarce. In a new study, researchers offered germline whole-genome sequencing to all participants diagnosed with Wilms tumors from 2016 to 2021 in Denmark. [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-06T16:10:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T00:16:10+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze)\",\"datePublished\":\"2023-04-06T16:10:11+00:00\",\"dateModified\":\"2026-02-23T00:16:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/\"},\"wordCount\":166,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/\",\"name\":\"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2023-04-06T16:10:11+00:00\",\"dateModified\":\"2026-02-23T00:16:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/04\\\/06\\\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/","og_locale":"en_US","og_type":"article","og_title":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog","og_description":"Wilms tumors, a rare form of kidney cancer that typically affects children, can be caused by high-penetrance genetic or epigenetic factors. However, studies systematically examining both these aspects of the disease are scarce. In a new study, researchers offered germline whole-genome sequencing to all participants diagnosed with Wilms tumors from 2016 to 2021 in Denmark. [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/","og_site_name":"JMG Contact blog","article_published_time":"2023-04-06T16:10:11+00:00","article_modified_time":"2026-02-23T00:16:10+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze)","datePublished":"2023-04-06T16:10:11+00:00","dateModified":"2026-02-23T00:16:10+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/"},"wordCount":166,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/","url":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/","name":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2023-04-06T16:10:11+00:00","dateModified":"2026-02-23T00:16:10+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/04\/06\/germline-epigenetics-reveals-high-predisposition-in-females-a-5-year-nationwide-prospective-wilms-tumour-cohort\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort (Contributed by Dr. Ulrik Kristoffer Stoltze)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1842"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1842\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}